Author: Ivan Cheung, Chairman & CEO, Eisai Inc. Eisai’s culture is defined by our human health care (hhc) mission, which guides the work we do to help increase the benefits health care provides...

By Neriman Botas, Executive Vice President, Human Resources Throughout the discussion and debate in the emerging post-pandemic world about work-life balance and transition “back to the workplace,”

How Eisai is utilizing digital workspace innovations in a post-pandemic era

When Eisai began planning the move to our new U.S. headquarters, the Eisai U.S. hhceco Center, in Nutley, New Jersey, we considered ways we could minimize the potential environmental impact. Any...

By Tushar Patel Vice President, US Sleep-Wake Commercial and Global Strategic Marketing, Neurology Business Group Each March, many Americans look forward to advancing our clocks by one hour as...

By Joye Bramble PhD, Exton Site Head and Vice President, Biopharmaceutical Development at Eisai US Our scientific understanding of cancer has undergone a significant transformation over the last...

By Patrick Coyle Patrick's blog is inspired by lessons of leadership, passion for people, and elevating each experience to fulfill and bundle the collective energy to achieve meaningful outcomes....

Ronak Patel Adelle Berezinsky Dr. Vivek Subbiah, M.D. Associate Director, Scientific Engagement and Digital Communications Eisai Director, Medical Information and Education Eisai Executive Medical...

Learn from oncology experts Eleonora Teplinsky, MD, a breast and gynecologic medical oncologist at Valley Health System, Melissa Wilson, MD, PhD, a medical oncologist at St. Luke’s University...

Ivan Cheung, Chairman, Eisai Inc. and Global President, Neurology Business Group, Eisai Co., Ltd. & Harald Hampel, MD, PhD, Vice President, Chief Medical Officer, Neurology Business Group, Eisai Inc.

How we’re leveraging each other’s unique strengths to help advance cancer research

By Teresa Cronin As we celebrate National Nurses Month, Eisai would like to pay special tribute to the nurses who inspire all of us, and in particular to Florence Nightingale as she was the...

As we recognize National Women’s Health Week, I consider how far collectively academia, the clinical community and industry have come in advancing treatments for women’s cancers. Work to...

By Renee Campbell, MD, MBA, MPH, Global Value and Access Epilepsy and Sleep lead, Genevieve De Sousa Meier, Executive Director, Head of Global Value and Access, and Amir Abbas Tahami Monfared,...

By Feride Frech, PhD, MPH, Senior Director, US HEOR & RWE, Eisai Inc, and Timothy Juday, Director, US HEOR & RWE, Eisai Inc. Insomnia, the most common sleep-wake disorder, is prevalent in the...

Harald Hampel, MD, PhD Vice President, Chief Medical Officer, Neurology Business Group, Eisai Inc. Alzheimer’s disease (AD) is a devastating neurodegenerative disease. It is estimated to affect...

By Jeff Somers, For years, the treatment of Alzheimer’s disease focused on symptoms. New research targets the pathophysiological changes underneath — with potentially promising results....

Though many people with insomnia go into doctor’s visits expecting a drug to relieve their sleeplessness, stakeholders are moving increasingly toward holistic approaches. Clinicians, medical...

It is no surprise that sleep problems are on the rise due to life changes caused by the coronavirus disease 2019 (COVID-19) pandemic. Based on my experience, the current environment, with myriad...

The European Society for Medical Oncology (ESMO) Virtual Congress 2020 took place from September 19-21. The theme of this year’s conference was “Bringing Innovation to Cancer Care”. Our...

By Shrividya Iyer, PhD, Oncology Lead, US HEOR & RWE, and Sanjay Gupta, PhD, MBA, Department Head, Health Economics, Outcomes Research and Real World Evidence Over the past decade, the term...

By Caroline Ojaimi, Director, US Medical Affairs, Strategy and Operations In late 2019, before the coronavirus pandemic, our Medical Affairs team at Eisai realigned our priorities. We agreed that...

By Luca Dezzani, Vice President, U.S. Medical Affairs, Oncology Business Group In the wake of COVID-19, we were forced into a virtual world that, in many ways, we weren’t entirely ready for. We...

By Asya Kogan, Executive Director, Field Medical, Oncology, Eisai For a medical science liaison (MSL), being “in the field” isn’t what it used to be. Over the years, quite a lot has...

By Tracey Cannova, Associate Medical Director, US Oncology Medical AffairsBy Tracey Cannova, Associate Medical Director, US Oncology Medical Affairs Working in medical affairs is exciting and...